{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12834607",
  "DateCompleted": {
    "Year": "2003",
    "Month": "07",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0021-9975",
      "JournalIssue": {
        "Volume": "128",
        "Issue": "4",
        "PubDate": {
          "Year": "2003",
          "Month": "May"
        }
      },
      "Title": "Journal of comparative pathology",
      "ISOAbbreviation": "J Comp Pathol"
    },
    "ArticleTitle": "Cyclin D1 expression in pre-cancerous and cancerous lesions of the canine mammary gland.",
    "Pagination": {
      "StartPage": "245",
      "EndPage": "251",
      "MedlinePgn": "245-51"
    },
    "Abstract": {
      "AbstractText": [
        "Overexpression of cyclin D1, the regulatory subunit of cyclin-dependent kinases (cdk4 and cdk6) involved in cell cycle control, has often been found in breast cancer and other types of human cancer. Increased expression, or stability, of cyclin D1 molecules may cause sufficient cdk4 activation to produce retinoblastoma protein phosphorylation independently of mitogenic signals; this results in commitment of cells to the G1 phase at mitosis. In the present study, cyclin D1 expression was investigated in pre-cancerous and cancerous lesions of the canine mammary gland by a complex experimental approach, which included Western blot and immunohistochemical analysis of cyclin D1 and the related molecular system. Furthermore, to define relationships between cell growth and expression of cyclin D1, proliferative activity was studied by the AgNOR technique. The study provided the following information. Cyclin D1 overexpression was largely independent of the type of proliferative anomaly. Indeed, cyclin D1 was expressed in 60% of the pre-cancerous lesions and in 44% of cancerous lesions. Mitotic activity and cyclin D1 expression were related: mammary lesions that expressed cyclin D1 showed a high proliferative ratio, the opposite being true of cyclin D1-negative cell populations. This study may contribute to the establishment of an animal model for anti-cancer research based on cyclin D1 suppression or cdk inactivation, or both."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Veterinary Pathology, Faculty of Veterinary Medicine, University of Messina, Polo Universitario dell'Annunziata, Italy."
          }
        ],
        "LastName": "Sfacteria",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bertani",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Costantino",
        "ForeName": "G",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Del Bue",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Paiardini",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cervasi",
        "ForeName": "B",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Piedimonte",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "De Vico",
        "ForeName": "G",
        "Initials": "G"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Comp Pathol",
    "NlmUniqueID": "0102444",
    "ISSNLinking": "0021-9975"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "136601-57-5",
      "NameOfSubstance": "Cyclin D1"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism",
        "pathology",
        "veterinary"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "veterinary"
      ],
      "DescriptorName": "Blotting, Western"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology",
        "veterinary"
      ],
      "DescriptorName": "Carcinoma in Situ"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Cyclin D1"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Dog Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dogs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "veterinary"
      ],
      "DescriptorName": "Immunoenzyme Techniques"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Mammary Glands, Animal"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Mammary Neoplasms, Animal"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nucleolus Organizer Region"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology",
        "veterinary"
      ],
      "DescriptorName": "Precancerous Conditions"
    },
    {
      "QualifierName": [
        "veterinary"
      ],
      "DescriptorName": "Silver Staining"
    }
  ]
}